Therapeutic avenues for targeting treatment challenges of diffuse midline gliomas
Authors:
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Rogel Cancer Center, University of Michigan
This publication has 118 references indexed in Scilit:
- PD-0332991, a CDK4/6 Inhibitor, Significantly Prolongs Survival in a Genetically Engineered Mouse Model of Brainstem GliomaPLOS ONE, 2013
- In Vitro Drug Response and Efflux Transporters Associated with Drug Resistance in Pediatric High Grade Glioma and Diffuse Intrinsic Pontine GliomaPLOS ONE, 2013
- Dual Inactivation of Akt and ERK by TIC10 Signals Foxo3a Nuclear Translocation, TRAIL Gene Induction, and Potent Antitumor EffectsScience Translational Medicine, 2013
- Co-administration strategy to enhance brain accumulation of vandetanib by modulating P-glycoprotein (P-gp/Abcb1) and breast cancer resistance protein (Bcrp1/Abcg2) mediated efflux with m-TOR inhibitorsInternational Journal of Pharmaceutics, 2012
- A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage responseNature, 2012
- Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomasNature Genetics, 2012
- A unique P-glycoprotein interacting agent displays anticancer activity against hepatocellular carcinoma through inhibition of GRP78 and mTOR pathwaysBiochemical Pharmacology, 2011
- Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine gliomaProceedings of the National Academy of Sciences, 2011
- HDAC inhibitor PCI-24781 decreases RAD51 expression and inhibits homologous recombinationProceedings of the National Academy of Sciences, 2007
- Magnetic Resonance Scans Should Replace Biopsies for the Diagnosis of Diffuse Brain Stem GliomasNeurosurgery, 1993